Tofacitinib cream plus narrowband ultraviolet B phototherapy for segmental vitiligo in a child. Issue 4 (7th April 2020)

• Record Type: Journal Article
• Authors: Olamiju, Brianna; Craiglow, Brittany G.
• Is Part Of: Pediatric dermatology. Volume 37:Issue 4(2020)
• Page Start: 754
• Page End: 755
• Publication Date: 2020-04-07
• Subjects: JAK inhibitor -- Janus kinase inhibitor -- pediatric -- segmental vitiligo -- tofacitinib -- topical -- treatment -- vitiligo; Pediatric dermatology -- Periodicals; Children -- Diseases -- Periodicals; 618.925
• DOI: 10.1111/pde.14159
• Languages: English
• ISSNs: 0736-8046

Abstract

Abstract: Segmental vitiligo often presents in childhood and tends to be more recalcitrant to therapy than generalized vitiligo. Recently, Janus kinase inhibitors have emerged as a promising treatment option, with some reports suggesting that concomitant ultraviolet light exposure may enhance therapeutic response. Here, we present a child with segmental vitiligo who responded rapidly and completely to treatment with tofacitinib cream plus phototherapy.